142 related articles for article (PubMed ID: 19959750)
1. Functional autoantibodies cause hypoparathyroidism.
Husebye ES
J Clin Endocrinol Metab; 2009 Dec; 94(12):4655-7. PubMed ID: 19959750
[No Abstract] [Full Text] [Related]
2. Hypoparathyroidism and autoimmune polyendocrine syndromes.
Schott M; Scherbaum WA
N Engl J Med; 2004 Sep; 351(10):1032-3; author reply 1032-3. PubMed ID: 15342816
[No Abstract] [Full Text] [Related]
3. Auto-immune hypoparathyroidism.
Weetman AP
Ann Endocrinol (Paris); 2015 May; 76(2):89-91. PubMed ID: 25913523
[No Abstract] [Full Text] [Related]
4. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
Brown EM
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):437-45, x. PubMed ID: 19328421
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M; Björklund P; Hallgren A; Pöntynen N; Szinnai G; Shikama N; Keller MP; Ekwall O; Kinkel SA; Husebye ES; Gustafsson J; Rorsman F; Peltonen L; Betterle C; Perheentupa J; Akerström G; Westin G; Scott HS; Holländer GA; Kämpe O
N Engl J Med; 2008 Mar; 358(10):1018-28. PubMed ID: 18322283
[TBL] [Abstract][Full Text] [Related]
6. [Hypoparathyroidism associated with autoimmune disorder].
Yamauchi M; Sugimoto T
Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
[TBL] [Abstract][Full Text] [Related]
7. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.
Kifor O; McElduff A; LeBoff MS; Moore FD; Butters R; Gao P; Cantor TL; Kifor I; Brown EM
J Clin Endocrinol Metab; 2004 Feb; 89(2):548-56. PubMed ID: 14764760
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism.
Tomar N; Kaushal E; Das M; Gupta N; Betterle C; Goswami R
J Clin Endocrinol Metab; 2012 Apr; 97(4):1219-26. PubMed ID: 22278434
[TBL] [Abstract][Full Text] [Related]
9. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.
Gylling M; Kääriäinen E; Väisänen R; Kerosuo L; Solin ML; Halme L; Saari S; Halonen M; Kämpe O; Perheentupa J; Miettinen A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4602-8. PubMed ID: 14557429
[TBL] [Abstract][Full Text] [Related]
10. AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED.
Cervato S; Morlin L; Albergoni MP; Masiero S; Greggio N; Meossi C; Chen S; del Pilar Larosa M; Furmaniak J; Rees Smith B; Alimohammadi M; Kämpe O; Valenzise M; Betterle C
Clin Endocrinol (Oxf); 2010 Nov; 73(5):630-6. PubMed ID: 20718774
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and classification of autoimmune parathyroid disease.
Betterle C; Garelli S; Presotto F
Autoimmun Rev; 2014; 13(4-5):417-22. PubMed ID: 24424178
[TBL] [Abstract][Full Text] [Related]
12. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
[TBL] [Abstract][Full Text] [Related]
13. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.
Gavalas NG; Kemp EH; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2007 Jun; 92(6):2107-14. PubMed ID: 17374709
[TBL] [Abstract][Full Text] [Related]
14. Disclosure of novel autoantigens in human autoimmunity .
Mirakian R; Locatelli M; Bottazzo GF
Lancet; 1998 Jul; 352(9124):255-6. PubMed ID: 9690403
[No Abstract] [Full Text] [Related]
15. [Hypoparathyroidism, ovarian insufficiency and adrenal insufficiency of autoimmune origin].
Homberg JC
Rev Prat; 1986 Dec; 36(59-60):3505-9. PubMed ID: 3809948
[No Abstract] [Full Text] [Related]
16. Association of HLA-CW3 with type 1 diabetes mellitus and idiopathic hypoparathyroidism in the Japanese.
Honda M; Fukumoto S; Fujita T; Oka Y; Asano T
Endocr J; 2002 Dec; 49(6):653-4. PubMed ID: 12625416
[No Abstract] [Full Text] [Related]
17. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.
Li Y; Song YH; Rais N; Connor E; Schatz D; Muir A; Maclaren N
J Clin Invest; 1996 Feb; 97(4):910-4. PubMed ID: 8613543
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.
Kemp EH; Kahaly GJ; Porter JA; Frommer L; Weetman AP
Clin Endocrinol (Oxf); 2018 Jan; 88(1):139-145. PubMed ID: 28941288
[TBL] [Abstract][Full Text] [Related]
19. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.
Kemp EH; Gavalas NG; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2009 Dec; 94(12):4749-56. PubMed ID: 19837919
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor.
Chamberlin M; Kemp EH; Weetman AP; Khadka B; Brown EM
Clin Endocrinol (Oxf); 2019 Jan; 90(1):214-221. PubMed ID: 30358904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
